China Strategic Technology Group Limited (the “Group”) announced that unaudited revenue for June 2026 reached RMB 58.11 million, more than doubling the RMB 28.55 million recorded in June 2025. The 103.54% year-on-year increase reflects sustained momentum across the Group’s core operations.
Management attributed performance to the breadth of its technology-driven portfolio:
• CT Aerospace: production of titanium alloy materials and satellite components, alongside digital applications and small unmanned spacecraft R&D.
• CT Precision Manufacturing: electronic manufacturing services, printed circuit board assembly, energy and thermal management systems, and industrial sensor solutions.
Growth initiatives continue in two emerging segments: 1) CT Vessel – development of new-energy commercial and civilian vessels integrating aerospace-derived energy storage and precision manufacturing know-how. 2) CT Biotechnology – R&D and commercialisation of biotechnology applications, including life engineering and biomedicine.
The Group positions its multi-sector integration—spanning aerospace, intelligent manufacturing, shipbuilding and biotechnology—as the core driver for long-term, diversified expansion.
All disclosed figures are preliminary and unaudited; they may differ from the results to be published in forthcoming statutory financial statements.
Comments